EuCARE school project: effectiveness of the Lolli-Methode in managing Covid-19 clusters and positivity rates in schools, Poster presented by Francesca Incardona
Doi G, Bellerba F, Santos A, Lopalco P, Gabellone V, Bardeck N, Rubio Quintanares G, Tucci G, Mainetti M, Andreon C, Mommo C, Fanti I, Abecasis A, Kaiser R, Gandini S,

23rd European Meeting on HIV &Hepatitis 2025

​

Learning loss and psychological outcomes in schools during the COVID-19 Pandemic: evidence from the EuCARE international cluster randomised trial, Poster presented by Francesca Incardona Bellerba F, Doi G, Tomezzoli E, Raimondi S, Cutica I, Mazzoni D, Martins Alves I, de Oliveira Tomás dos Santos A, Lopalco P, Gabellone V, Bardeck N, Rubio Quintanares G, Andreon C, Mainetti M, Tucci G, Mommo C, Fanti I, Abecasis A, Kaiser R, Incardona F, Gandini S

23rd European Meeting on HIV &Hepatitis 2025

​

Early Detection of SARS-CoV-2 Variants in a School Cohort Using Next-Generation Sequencing: Insights from the EUCARE Project, Oral presentation by Dr. Ana Abecasis
Santos A, Pimentel V, Alves I, Sebastião C, Miranda M, Seabra S, Raimondi S, Gandini S, Quintanares G, Lopalco P, D’Ecclesiis O, Tomezzoli E, Mommo C, Fanti I, WP4 E, Bellerba F, Kaiser R, Bardeck N, Martins M, Toscano C, Incardona F, Viveiros M, Pingarilho M, Abecasis A
23rd European Meeting on HIV &Hepatitis 2025

​

Exploring mental health and learning loss of students during the COVID-19 Pandemic: an international study within the EuCARE project, Oral presentation by Dr. Federica Bellerba
Federica Bellerba, Giulia Doi, Elisa Tomezzoli, Sara Raimondi, Ilaria Cutica, Davide Mazzoni, Inês Martins Alves, André Filipe Bruno de Oliveira Tomás dos Santos, Pier Luigi Lopalco, Valeria Gabellone, Nils Bardeck, Gibran Horemheb Rubio Quintanares, Giuseppina Tucci, Chiara Mommo, Iuri Fanti, Ana Abecasis, Rolf Kaiser, Francesca Incardona, Sara Gandini
The Pandemic EVIDENCE Collaboration 2025 International Conference

​

Effectiveness of the Lolli-methode in managing covid-19 clusters in schools: insights from the EuCARE project, Oral presentation by Dr. Giulia Doi

Giulia Doi, Federica Bellerba, Inês Martins Alves, André Filipe Bruno de Oliveira Tomás dos Santos, Pier Luigi Lopalco, Valeria Gabellone, Nils Bardeck, Gibran Horemheb Rubio Quintanares, Giuseppina Tucci, Chiara Mommo, Iuri Fanti, Ana Abecasis, Rolf Kaiser, Sara Gandini, Francesca Incardona 

The Pandemic EVIDENCE Collaboration 2025 International Conference

​

Trajectories and Predictors of Post-COVID-19 Condition Persistence: a prospective evaluation in the EuCARE Study, Andrea Santoro, Claudia Acampora, Maria Francesca Greco, V. Sala, Francesca Ceccherini-Silberstein, Iuri Fanti, Francesca Incardona, J. Andrade Pinto, Gibran Horemheb Rubio Quintanares, Cristina Toscano, Alessandro Cozzi-Lepri, Camilla Tincati, Giulia Marchetti on behalf of EuCARE Study Group

17th Italian Conference on AIDS and Antiviral Research (ICAR 2025)

​

Psychological outcomes and learning loss in students after the COVID-19 pandemic: findings from EuCARE’s SCHOOL studies, Francesca Incardona
Federica Bellerba, Giulia Doi, Inês Martins Alves, André Filipe Bruno de Oliveira Tomás dos Santos, Pier Luigi Lopalco, Valeria Gabellone, Nils Bardeck, Gibran Horemheb Rubio Quintanares, Giuseppina Tucci, Chiara Mommo, Iuri Fanti, Ana Abecasis, Rolf Kaiser, Sara Gandini, Francesca Incardona
17th Italian Conference on AIDS and Antiviral Research (ICAR 2025)

​

Reduction of post COVID-19 condition during the Omicron wave: results from the EuCARE POSTCOVID Study, Andrea Santoro
Francesca Bai, Alessandro Cozzi-Lepri, Pontus Hedberg, Andrea Santoro, Maria Francesca Greco, Matteo Sala, Julia Fonseca de Morais Caporali, Carolina Coimbra Marinho, Maria Mercedes Santoro, Francesca Ceccherini Silberstein, Dovile Juozapaite, Edita Strumiliene, André Almeida, Cristina Toscano, Jesus Arturo Ruiz Quinones, Chiara Mommo, Iuri Fanti, Francesca Incardona, Giulia Marchetti on behalf of the EuCARE Project
34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) 

​

In-Hospital Mortality During Different SARS-CoV-2 Variant Waves in the EuCARE Multinational Cohort, Pontus Hedberg, Milosz Parczewski, Giulia Marchetti, Björn Jensen, Francis Drobniewski, Daniel Naumovas, Francesca Ceccherini-Silberstein, Gibran Horemheb Rubio Quintanares, Matilu Mwau, Cristina Toscano, Maurizio Zazzi, Alessandro Cozzi-Lepri, Anders Sönnerborg, Pontus Nauclér

Conference on Retroviruses and Opportunistic Infections- CROI 2024

​

Preliminary results of the Eucare school studies and SARS CoV 2 trends in Italy, Germany and Portugal and school opening during the Omicron variant,  Federica Bellerba, Nils Bardeck, Michael Böhm, Rolf Kaiser, Elisa Tomezzoli, Ana Abecasis, Oriana D’Ecclesiis, Francesca Incardona, Chiara Mommo, Iuri Fanti, Valeria Gabellone, Giulia Vaglio, Pierluigi Lopalco, Marta Pingarilho, Ines Martins Alves, Daniela Alves, Gibran Rubio Horemheb, Martin Pirkl, Sara Gandini 

21st European Meeting on HIV & Hepatitis 2023

​

Analysis of mutational history of multi-drug resistance with a mutagenetic tree model, Martin Pirkl et al. 

European Meeting on HIV & Hepatitis 2022 (Paris)

​

Declining incidence of HIV multidrug resistance in Europe, J. Dewandre, J. Vercauteren, A.-M. Vandamme, B. Rossetti, M. Fabbiani, F. Incardona, A. Abecasis, C. Devaux, R. Kaiser, A. Sönnerborg, M. Zazzi, The EuResist Network study group

18th European AIDS Conference (EACS),  2021

4-Class Resistance is rare in treatment experienced patients across Europe, M. Zazzi, A.M. Vandamme, B. Rossetti, M. Fabbiani, F. Incardona, K. Theys, A. Abecasis, C. Devaux, R. Kaiser, A. Sönnerborg, G. Pasculli, J. Vercauteren for the EuResist Network study group

CROI 2020

​

Prevalence and spatiotemporal dynamics of the HIV-1 circulating recombinant form 03_AB (CRF03_AB) in the former Soviet Union, Ozhmegova E, Lebedev A, Pasechnik O, Blokh A, Grezina L, Dementeva N, Sandyreva T, Kazennova E and Bobkova M, 

18th European meeting on HIV and hepatitis, 2020

​

Susceptibility to HIV – integrase inhibitors in HIV-1 sub subtype A6 isolates, Giannini A, Giammarino F, Antonova A, Ozhmegova E, Kaiser R, Dragoni F, Boccuto A, Vicenti I, Sönnerborg A, Bobkova M, Zazzi M, Saladini F, 

ICAR Conference, 2020,

Poster session “Best of Posters” 18th European Meeting on HIV & Hepatitis,2020

​

A changing of HIV-1 genetic diversity in Russia during the last two decades: increase of the recombinants prevalence, Antonova A, Kazennova E, Bobkova M, 18th European meeting on HIV and hepatitis, 2020

​

High throughput sequencing for in depth analysis of pre-treatment HIV-1 drug resistance in Sweden, Andersson E, Ambikan A, Brännström J, Aralaguppe S, Yilmaz A, Albert J, Neogi U, Sönnerborg A. 

6th Nordic HIV and Hepatitis Conference 2019

​

HTS methodology and the bioinformatic pipeline for A6 HIV-1 sub-sub.type. Anders Sonnerborg et al. 

6th Nordic HIV and Hepatitis Conference 2019

​

Current trends in HIV genetic diversity in Russia: increased prevalence of unique recombinant variants. Antonova A, Lebedev A, KaBob E.

17th European AIDS Conference – EACS  2019

​

Analysis of the local HIV-1 epidemic in Vologda Region, Russia: predominance of CRF03_AB and rapid expansion of URFs, Ozhmegova E, Lebedev A, Krylova T, Kirillova I, Dementeva N, Kazennova E, Bobkova M. 

17th European AIDS Conference – EACS  2019

​

HIV-1 A6 subtype: its challenging identification and Southern Russian molecular epidemiology. Rolf Kaiser et al. 

EACS 2019

​

Genotypic susceptibility score of NRTI-backbone predicts time to virological failure of InSTIs-based regimens. A. Borghetti, A. Ciccullo, F. Lombardi, G. Baldin, S. Belmonti, M. Prosperi, F. Incardona, E. Heger, V. Borghi, A. Sönnerborg, M. Zazzi, A. De Luca, S. Di Giambenedetto.

CROI 2019

​

Integrating EuResist database with integrase resistance data for optimized antiretroviral treatment (the INTEGRATE project), Maurizio Zazzi, Ana Abecasis, Marina Bobkova, Carole Devaux, Iuri Fanti, Francesca Incardona, Rolf Kaiser, Gaetano Marrone, Roger Paredes, Stefano Rusconi, Murat Sayan, Anders Sönnerborg and Andrea De Luca for the EuResist Network and the INTEGRATE study group.

EACS 2017

​

Predicting human-immunodeficiency virus rebound after therapy initiation/switch using genetic, laboratory, and clinical data ||

Mattia Prosperi, Alejandro Pironti, Francesca Incardona, Giuseppe Tradigo, Maurizio Zazzi – BCB ’16 Proceedings of the 7th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics – 2016, Pages 611-615 

​

HIV superinfection does not contribute to transmitted drug resistance. (Poster) || Bartha I, M Assel, P Sloot, M Zazzi, C Torti, E Schülter, A de Luca, A Sönnerborg, AB. Abecasis, K Van Laethem, A Rosi, J Svärd, R Paredes, DAMC van de Vijver, A-M Vandamme and V Müller. 20th International HIV Dynamics and Evolution Meeting. 8-11 May 2013, Utrecht, The Netherlands.

​

Transmitted Drug-Resistance Associated Mutations (TDRAMs) in HIV-1 Protease are Correlated with a Faster Pre-Therapy Decline in CD4+ T-Cell Count. (Poster) – Albini L., BM. Cesana, K. Theys, M. Zazzi, C. Boucher, R. Paredes, A. Sonnerborg, AM. Geretti, A-M. Vandamme, C. Torti. 17th International Workshop on HIV Observational Databases. Cavtat, Croatia, 11-13 April 2013.

Clinical evaluation of Rega 8: An updated genotypic interpretation system that significantly predicts HIV-therapy response.(Poster) – Vercauteren J, Beheydt G, Prosperi M, Libin P, Imbrechts S, Camacho R, Clotet  B, De Luca A, Grossman Z, Kaiser R, Sönnerborg A, Torti C, Van Wijngaerden E, Schmit JC, Zazzi M, Geretti AM, Vandamme A-M, Van Laethem K. 11th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance. Rome, Italy, March 20-22, 2013. 

A large scale analysis of a subtype-dependent impact of K65R selection in HIV-1 patients treated with cART including TDF (Poster) – Theys K., J. Vercauteren, J. Snoeck,  Z. Grossman, B. Clotet, A. De Luca, R. Kaiser, A. Sonnerborg, C. Torti, J.-C. Schmit, M. Zazzi, R. Camacho, A.-M. Vandamme and A. Abecasis, in collaboration with the EuResist consortium. 10th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain. 28-30 March, 2012.

​

Bayesian Network Analysis of Mutational Pathways to Darunavir Resistance (Poster) – Beheydt G, Theys K, Clotet B, Schülter E, Schmit J-C, Sönnerborg A, Zazzi M, Van Laethem K, Camacho R, Vandamme AM. Nineteenth Conference on Retroviruses and Opportunistic Infections. March 5-8, 2012. Seattle. Link

​

Training and strategy for HIV drug resistance testing in Eastern Africa – Maurizio Zazzi, Genny Meini, Arthur Emary, Nigus Fikrie, Silvia Kadima, Ezekiel Marandu, Doreen Mloka, Sabina Mugusi, Stephen Mutuku, Washington Njogu, Amare Worku, Muhammad Bakari, Daniel Fekade, Ferdinand Mugusi, Matilu Mwau, Mario Toti, Francesca Incardona, Anders Sonnerborg. Sixth EDCTP Forum, 9-12 October 2011, Addis Ababa, Ethiopia

​

Impact of natural polymorphisms of HIV-1 reverse transcriptase on virologic response to a first line NNRTI-containing HAART – Santoro MM, Svicher V, Cozzi-Lepri A, Fabeni L, Bruzzone B, Mussini C, De Luca A, Andreoni M, Antinori A, Zazzi M, Perno CF, D’Arminio Monforte A, Ceccherini-Silberstein F for Icona Foundation 15th International Workshop on HIV Observational Databases, Praha, 24-26 March 2011

Consensus Statement version 1.0 – Vandekerckhove LPR, Wensing AMJ, Kaiser R, Brun-Vézinet F, Clotet B, De Luca A, Dressler S, Garcia F, Geretti AM, Klimkait T, Korn K, Masquelier B, Perno CF, Schapiro JM, Soriano V, Sönnerborg A, Vandamme AM, Verhofstede C, Walter H, Zazzi M and Boucher CAB on behalf of the European Consensus Group on clinical management of tropism testing. European guidelines on clinical management of HIV-1 tropism testing 9th European Workshop on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, Cyprus. 23-25 March 2011

A system to query distributed heterogeneous viral databases – Beheydt G, Schülter E, Imbrechts S, Abecasis A, Codoñer FM, Paraskevis D, Sönnerborg A, Vandamme AM, Kjaer J. – 9th European Workshop on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance. 23-25 March 2011, Cyprus

​

HIV-1 gp120 substitutions and plasma maraviroc concentration: contribution to virological failure during maraviroc-based salvage therapy – Di Giambenedetto S, Santangelo R, Meini G, Fabbiani M, Prosperi M, Marchetti S, Fortuna S, Navarra P, Fadda G, Cauda R, Zazzi M, De Luca A 9th European Workshop on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, Cyprus, 23-25 March 2011

A computational method for predicting first-line HIV antiretroviral therapy success  – Pironti A, Altmann A, Schulter E, Boch J, Balduin M, Reuter S, Zazzi M, van de Vijver D, Oette M, Kaiser R, Lengauer T 9th European Workshop on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, Cyprus. 23-25 March 2011

​

Declining differences in treatment outcome among different patient categories in Europe, 1992-2010 (Abstract O29) (Oral) – Rosen-Zvi M1, Zazzi M2, Incardona F 3, Aaroni E1, Kaiser R 4, Lengauer T 5, Camacho R6, Clotet B 7, Vandamme AM8, Schmit JC9 , Sönnerborg A10 – for the EuResist Network 9th European Workshop on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, Cyprus, 23-25 March 2011. Reviews in Antiviral Therapy & Infectious Diseases 2:32, 2011.

​

A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen – Prosperi MCF, Di Giambenedetto S, Fanti I, Meini G, Bruzzone B, Callegaro A, Penco G, Bagnarelli P, Micheli V, Paolini E, Di Biagio A, Ghisetti V, Di Pietro M, Zazzi M, De Luca A 9th European Workshop on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, Cyprus, 23-25 March 2011

​

Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing vs 1.0 – Vandekerckhove LPR, Wensing AMJ, Kaiser R, Brun-Vézinet F, Clotet B, De Luca A, Dressler S, Garcia F, Geretti AM, Klimkait T, Korn K, Masquelier B, Perno CF, Schapiro JM, Soriano V, Sönnerborg AM, Vandamme AM, Verhofstede C, Walter H , Zazzi M, Boucher CAB on behalf of the European Consensus Group on clinical management of tropism testing Tenth International Congress on Drug Therapy in HIV Infection. Glasgow, UK, 7-11 November 2010

​

The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds (Abstract 06) (Oral) – Pironti A, Sönnerborg A, Zazzi M, Kaiser R, Struck D, Clotet B, Vandamme AM, Incardona F, Lengauer T, Rosen-Zvi T, Prosperi M. Tenth International Congress on Drug Therapy in HIV Infection. Glasgow, UK, 7-11 November 2010

​

Learning ancestral polytrees for HIV-1 mutation pathways against protease inhibitor (Abstract 64) (Poster) – Nelfinavir Li G, Beheydt G, Bielza C, Larrañaga P, Camacho R, Grossman Z, Torti C, Zazzi M, Prosperi M, Kaiser R, Van Laethem K, De Maeyer M, Jansen M, Vandamme A-M. Ninth European Conference on Computational Biology, Ghent, Belgium, September 26-29, 2010

​

The genotypic susceptibility score of Rega v8.0.2 after treatment failure (Abstract 12) (Poster) – Beheydt G, Zazzi M, Carvalho AP, Diogo I, Ram D, Rudich H, Camacho R, Grossman Z. 16th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology, Bethesda, USA, 29 August – 3 September 2010

​

Estimating the frequency of superinfection in a large European collaborative HIV database (Abstract FRAA0102) (Oral) -Bartha I, Assel M, Sloot P, Zazzi M, Torti C, Kaiser R, de Luca A, Sonnerborg A, Vandamme A, Paredes R, van de Vijver D, Müller V. XVIII International AIDS Conference, Vienna, Austria, July 18-23, 2010

​

Evaluation of virological response to cART in patients carrying non-B subtype matched for baseline genotype with B subtype – Franzetti M, Casazza G, Meini G, Callegaro AP, Corsi P, Maggiolo F, Boeri E, Paolucci S, Gianotti N, Francisci D, Orani A, Filice G, Carli T, Zazzi M, Balotta C. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies, Dubrovnik, Croatia, June 8-12, 2010

​

Study of the Regimen-Specific HIV-1 Genotypic Susceptibility Score after Treatment Failure (Abstract 82) (Poster) – Beheydt G, Zazzi M, Carvalho AP, Diogo I, Ram D, Rudich H, Camacho R, Grossman Z, Van Laethem K, Vandamme A-M. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies, Dubrovnik, Croatia, June 8-12, 2010. Antiviral Therapy 2010, Vol. 15, Suppl. 2: A99

​

Pairwise comparison of genotypic coreceptor tropism prediction between one reference center and 10 European laboratories – Sierra S, Balduin M, Zazzi M, Sönnerborg A, Geretti AM, Vandekerckhove L, Verhofstede C, Berg J, Puchhammer-Stöckl E, Simon B, Kessler H, Wolf E, Thielen A, Däumer M, Kaiser R. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies, Dubrovnik, Croatia, June 8-12, 2010

​

Specific Genetic Signatures in V3 Base Can Modulate Co-receptor Usage in Vivo, the Interaction with Neutralizing Antibodies, and HIV-1 Cytopathic Effect – Svicher V, Alteri C, Artese A, Costa G, Mercurio F, D’Arrigo R, Alcaro S, Ceccherini F, Bagnarelli P, Antonelli G, Micheli V, Ghisetti V, Gennari W, Baldanti F, Callegaro AP, Bruzzone B, Fadda G, Re MC, De Luca A, Andreoni M, Antinori A, Zazzi M, Canducci F, Clementi M, Angarano G, Parisi S, Lazzarin A, Perno CF on behalf of OSCAR group. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies, Dubrovnik, Croatia, June 8-12, 2010

​

The EuResist Expert Model for Customised HAART Optimisation: 2010 Update and Extension to Newest Compounds – Pironti A, Sonnerborg A, Zazzi M, Kaiser R, Struck D, Clotet B, Vandamme A-M, Incardona F, Lengauer T, Rosen-Zvi M, Prosperi M Tenth International Congress on Drug Therapy in HIV Infection. 7-11 November 2010 Glasgow, UK.

​

The genotypic susceptibility score of Rega v8.0.2 after treatment failure – Beheydt G, Zazzi M, Carvalho AP, Diogo I, Ram D, Rudich H, Camacho R, Grossman Z, Vandamme A-M, Van Laethem K. 16th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology. 29 August – 03 September 2010, Bethesda, USA

​

Estimating the frequency of superinfection in a large European collaborative HIV database (Talk) – Bartha I, Assel M, Sloot P, Zazzi M, Torti C, Kaiser R, de Luca A, Sonnerborg A, Vandamme A, Paredes R, van de Vijver D, Müller V. XIII International AIDS Conference. Wien, July 18-23, 2010.

​

Study of the Regimen-Specific HIV-1 Genotypic Susceptibility Score after Treatment Failure (Talk) – Beheydt G, Zazzi M, Carvalho AP, Diogo I, Ram D, Rudich H, Camacho R, Grossman Z, Van Laethem K, Vandamme A-M. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies. June 8-12, 2010. Dubrovnik, Croatia.

​

Rega 8: an improved genotypic interpretation system that significantly predicts HIV-therapy response for B and non-B subtypes (Talk) (Abstract 50) – Beheydt G, Vercauteren J, Libin P, Imbrechts S, Camacho R, Clotet B, De Luca A, Grossman Z, Kaiser R, Sonnerborg A, Torti C, Van Wijngaerden E, Zazzi M, Geretti AM, Vandamme AM, Prosperi M. 8th European HIV Drug Resistance Workshop. 17-19 March 2010. Sorrento, Italy. Reviews in Antiviral Therapy 2010, 1:48-49. Poster

​

Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study). (Abstact 45) – Zazzi M, R Kaiser, A Sonnerborg, D Struck, A Altmann, M Prosperi, M Rosen-Zvi, A Petroczi, Y Peres, E Schulter, C Boucher, F Brun-Vezinet, P Harrigan, L Morris, M Obermeier, C Perno, P Phanuphak, D Pillay, R Shafer, A-M Vandamme, K Van Laethem, A Wensing, T Lengauer, F Incardona. 8th European HIV Drug Resistance Workshop. 17-19 March 2010. Sorrento, Italy. Reviews in Antiviral Therapy 2010, 1:43. Oral

​

Detection of drug resistance mutations (DRM) at low viral load in a European multicohort study (SEHERE) (Abstract and poster) – Prosperi M., Dunn D., Di Giambenedetto S., Zazzi M., Camacho R., Fanti I., Torti C., Sonnerborg A., Kaiser R., Codoñer F., Van Laethem K., Bansi L., Asboe D., van de Vijver D., De Luca A., for the Virolab, Euresist, Chain and Dynanets consortia. 8th European HIV Drug Resistance Workshop, Sorrento (Italy), 2010

​

New V3-genetic Signatures Modulate Co-receptor Usage in vivo and the Interaction with CCR5 N-terminus (Talk and poster) – Svicher V., Alteri C., Artese A., D’Arrigo R., Cammarota R., Alcaro S., Ceccherini F., Bagnarelli P., Antonelli G., Micheli V., Ghisetti V., Gennari W., Baldanti F., Callegaro A.P., Bruzzone B., Fadda G., Re M.C., De Luca A., Andreoni M., Antinori A., Zazzi M., Clementi M., Angarano G., Parisi S., Lazzarin A., Perno C.F. on behalf of OSCAR group. 8th European HIV Drug Resistance Workshop, Sorrento (Italy), 2010

​

Application of a probabilistic Optimization Method for Deriving Clinical Cutoffs for (Predicted) Durg Resistance Phenotypes (Poster) – Altmann A., Daumer M., Pironti A., Perner J., Buch J., Torti C., Prosperi M., Kaiser R., Lengauer T. 8th European HIV Drug Resistance Workshop, Sorrento (Italy), 2010

​

Untangling pathways to tipranavir resistance in patients infected with various HIV-1 subtypes (Abstract) – Theys K., Sangeda R.Z., Camacho R., Clotet B., Van Laethem K., Zazzi M., Sonnerborg A., Kaiser R., De Luca A., Torti C., Wensing A.M.J., Stanczak G., Linka M., Poljak M., Lepej S.Z., Van Wijngaerden E., Verhofstede C., Rhee S-Y, Vandamme A.M.for the EHR, Virolab, EuResist and BREACH Projects 12th European AIDS Conference/EACS, Cologne (Germany), November 11-14, 2009, Abstract PE7.4/9

​

Semi-Supervised Learning for Improving Prediction of HIV Drug Resistance (Talk) – Perner J., Altmann A., Lengauer T. In: Lecture Notes in Informatics, Proceedings of the German Conference on Bioinformatics 2009 (2009) vol. P-157 pp. 55-65

​

Calendar trends in antiretroviral drug resistance in treatment-experienced patients in Europe (Abstract) – Di Giambenedetto S., Dunn D., Zazzi M., Fanti I., Camacho R., Manca N., Kaiser R., Sonnerborg A., Codoner F.M., Van Laethem K., Bansi L., Ghisetti V., van de Vijver D., Assel M., Prosperi M., De Luca A. on behalf of Virolab, EuResist, Chain 12th European AIDS Conference/EACS, Cologne (Germany), November 11-14, 2009, Abstract PE3.1/8.

​

Prediction Of Antiretroviral Therapy Outcomes In Poor Resource Countries: Comparison Between Genotype Resistance Testing Based vs. Treatment History Models (Talk, Abstract) – Prosperi M.C.F., Rosen-Zvi M., Altmann A., Aharoni E., Peres Y., Sönnerborg A., Incardona F., Struck D., Kaiser R., Zazzi M. for the EuResist study Group. 5th EDCTP Forum, Arusha (Tanzania), October 12-14, 2009, selected as oral presentation.

​

Comparing the prevalence of  tipranavir resistance mutations in naïve, PI experienced and tipranavir experienced patients. (Poster) (Abstract 24) – 15th International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology, Rotterdam, The Netherlands, 7-11 September 2009.

​

Untangling Pathways to Tipranavir Resistance in HIV-1 Treatment Experienced Patients from Various Subtypes. (Poster) (Abstract 25) – Sangeda R, Theys K, Camacho R, Clotet B, Van Laethem K, Zazzi M, Sönnerborg A, Kaiser R, De Luca A, Torti C, Wensing A.M.J., Stanczak G, Linka M, Poljak M, Lepej SZ, Van Wijngaerden E, Verhofstede C, Rhee S-Y,  Vandamme A-M, for the EHR, Virolab, EuResist and BREACH projects. 15th International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology, Rotterdam, The Netherlands, 7-11 September 2009.

​

Expanding the world’s largest HIV drug resistance database, EuResist, into an African context (Talk, Abstract) – Incardona F., Aris E., Janabi M., Swai A., Mugusi F., Bakari M., Nagu T., Mugusi S., Mloka D., Wondwossen A., Lindquist L., Sönnerborg A., Zazzi M., Kaiser R., Lengauer T., Prosperi M.C.F., Altmann A., Sandstrom E. 5th EDCTP Forum, Arusha (Tanzania), 2009

​

Do not blame the fitness! – Only slight impact of predicted replicative capacity for therapy response prediction (Abstract) – Altmann A., Weisser H., Incardona F., Sonnerborg A., Zazzi M., Kaiser R., Lengauer T., Walter H. 7th European HIV Drug Resistance workshop, Stockholm (Sweden), March 25-27, 2009, Abstract Presentation

​

Evaluation of longitudinal fitness landscapes in prediction of treatment outcome in a clinical dataset of HIV-1 treated patients (Abstract) – Sangeda R.Z., Deforche K., Vercauteren J., Libin P., Imbrechts S., Theys K., Grossman Z., Camacho R., Van Laethem K., Zazzi M., Sönnerborg A., Kaiser R., De Luca A., Torti C., Ruiz L., van de Vijver D., Shafer R.W., Van Wijngaerden E., Vandamme A.M. for the Virolab and EuResist projects 7th European HIV Drug Resistance workshop, Stockholm (Sweden), March 25-27, 2009, Abstract Presentation

​

Keeping models that predict response to antiretroviral therapy up-to-date: fusion of pure data-driven approaches with rules-based methods (Abstract)– Altmann A., Thielen A., Frentz D., Van Laethem K., Bracciale L., Incardorna F., Sönnerborg A., Zazzi M., Kaiser R., Lengauer T. 7th European HIV Drug Resistance workshop, Stockholm (Sweden), March 25-27, 2009, Abstract Presentation

​

Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models (Abstract and poster) – Prosperi M., Rosen_Zvi M., Altmann A., Aharoni E., Peres Y., Sonnerborg A., Incardona F., Struck D., Kaiser R., Zazzi M. 7th European HIV Drug Resistance workshop, Stockholm (Sweden), March 25-27, 2009, Abstract Presentation

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) – Lengauer T. Keynote at ISMB/ECCB 2009, Stockholm (Sweden), 2009

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) – Lengauer T. ETH, Zürich (Switzerland), 2009

​

Do not blame the fitness! – Only slight impact of predicted replicative capacity for therapy response prediction (Talk) – Altmann A. Arevir Meeting, Bonn (Germany), 2009

​

Predicting virological response using genotypic approaches for Tenofovir (Talk, Abstract) – Frentz D., Boucher C.A.B., Assel M., Bubak M., De Luca A., Incardona F., Libin P., Ruiz L., Sloot P., Torti C., Vandamme A.M., Zazzi M., Van de Vijver D.A.M.C. 7th European HIV Drug Resistance workshop, Stockholm (Sweden), 2009

​

Predicting virological response by different systems interpreting genotypic HIV-1 drug resistance in a large European cohort (Talk) – Frentz D., Van de Vijver D.A.M.C., Altmann A., Assel M., De Luca A., Libin P., Müller V., Nualláin B. Ó., Prosperi M., Ruiz L., Sloot P., Schülter E., Torti C., Vandamme A.M., Boucher C.A.B. 7th European HIV Drug Resistance workshop, Stockholm (Sweden), 2009

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) – Lengauer T. Symposium “Systems Biology and Translatiuonal Pneumology”, Mannheim (Germany), 2009

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) – Lengauer T. University of Leuven, Germany, 2009

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) – Lengauer T. Freiburg University, Germany, 2009

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) – Lengauer T. Konstanz University, Germany, 2009

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) – Lengauer T. Hamburg University, Germany, 2009

​

Multi-task learning for hiv therapy screening – Bickel, Bogojeska, Lengauer and Scheffer Proceedings of the 25th annual International Conference on Machine Learning (ICML 2008), p. 56-63.

​

Inferring Virological Response from Genotype: With or without predicted phenotypes? (Talk) – Altmann A. Virco, Mechelen (Belgium), 2008

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) – Lengauer T. Workshop on Machine Learning, NIPS 2008, Vancouver (Canada), 2008

​

Genotypic methods for predicting HIV tropism (Talk) – Lengauer T. Forth HIV Entry Workshop, Puerto Rico, 2008

​

Bioinformatics: RESINA, geno2pheno and EuResist (Talk) Altmann A. 2nd HIV Resistance workshop, Robert Koch Institute, Berlin (Germany), 2008

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) Lengauer T. Heidelberg University, Germany, 2008

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) Lengauer T. Annual Meeting of the German Society for Fighting Viral Disease (DVV), Cologne (Germany), 2008

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) Lengauer T. Helmholtz Gymnasium Bonn, Germany, 2008

​

Sustaining lamivudine/emtricitabine, abacavir, zidovudine or atazanavir from a previous treatment shows a clinical benefit (Abstract and poster) Rosen-Zvi M., Schuelter E., Altmann A., Sierra-Aragon S., Zazzi M., Sonnerborg A., Oette M., Lengauer T., Kaiser R. on behalf of the EuResist Group 17th International HIV Drug Resistance Workshop, Sitges (Spain), June 10-14, 2008, Abstract Presentation

​

Chasing the AIDS Virus – Computational Biology comes to the help of AIDS patients (Talk) Lengauer T. Annual Meeting, Max Planck Society, Dresden (Germany), 2008

​

A system that learns from clinical-genomic patients data and generate recommendations on best therapy – the AIDS disease as a case study (Talk)Rosen-Zvi et al. Yearly meeting of information systems in medicine, Israel, 2008

​

Jagt auf das Virus – Hilfe fuer AIDS Patienten aus dem Computer (transl: “Chasing the Virus – Help for HIV patients from the Computer”) (Invited lecture) Lengauer T., Altmann A. Max Planck annual meeting, Munchen (Germany), 2008

​

EuResist: an integrated system for management of antiretroviral drug resistance (Talk) Incardona F. Third AREVIR RKI Meeting, Bonn (Germany), 2008

​

EuResist presentation (Talk) Prosperi M. Third AREVIR RKI Meeting, Bonn (Germany), 2008

​

Guiding treatment selection: past present and future (Talk) Altmann A. Third AREVIR RKI Meeting, Bonn (Germany), 2008

​

EuResist project (Talk) Zazzi M. Second Baltic-Swedish HIV Meeting, Tallinn (Hestonia), 2008

​

Resistance tests (Talk) Kaiser R. Second Baltic-Swedish HIV Meeting, Tallinn (Hestonia), 2008

​

Bionformatics helps to make sense of resistance (Talk) Lengauer T. Second Baltic-Swedish HIV Meeting”, Tallinn (Hestonia), 2008

​

Basics of HIV drug resistance and resistance to novel drugs (Talk) Sonnerborg A. Second Baltic-Swedish HIV Meeting”, Tallinn (Hestonia), 2008

​

The EuResist approach for predicting response to anti HIV-1 therapy Altmann A., Rosen-Zvi M., Prosperi M., Aharoni E., Neuvirth H., Schülter E., Büch J., Peres Y., Incardona F., Sönnerborg A., Kaiser R., Zazzi M., Lengauer T. 6th European HIV Drug Resistance Workshop, 26 to 28 March 2008, Budapest (Hungary), 2008

​

Sustaining 3TC/FTC, ABC, AZT or ATV from a previous treatment shows a clinical benefit (Poster) Rosen-Zvi et al. XVII International HIV Drug Resistance Workshop, Sitges (Spain), 2008

​

EuResist presentation (Talk) Rosen-Zvi M. IBM Student Reception, “NIPS conference”, Canada, 2007

​

Connections between network structure and functionality (Talk) Bazso F. Simonyi-day lecture, Budapest (Hungary), 2007

​

Data-mining on graphs, with application to mutation data (Talk) Bazso F. Simonyi-day lecture, Budapest (Hungary), 2007

​

Standard based interoperability middleware helps fight AIDS (Talk) Rosen-Zvi M. HL7 UK Conference: “Making Interoperability Work”, London (UK), 2007

​

EuResist presentation (Talk) Rosen-Zvi M. Healthcare and Life Sciences Seminar 2007, IBM Haifa Research Lab, Israel, 2007

​

EuResist presentation (Talk) Zazzi M. First Workshop on Italian HIV Cohorts, Siena (Italy), 2007

​

EuResist: An integrated system for management of antiretroviral drug resistance (Talk and poster) Incardona F. The World of Health It Conference & Exhibition, Wien (Austria), 2007

​

Likelihood-based clustering of directed graphs (Talk) Nepusz T., Bazsó F. Proceedings of the IEEE 3rd International Symposium on Computational Intelligence and Intelligent Informatics (March, 28-30, 2007) 1-4244-1158-0/07/$25.00 © 2007 IEEE

​

Integration of Viral Genomics with Clinical Data to Predict Response to Anti-HIV Treatment (Talk) Aharoni E., Altmann A., Borgulya G., D’autilia R., Incardona F., Kaiser R., Kent C., Lengauer T., Neuvirth H., Peres Y, Petroczi A., Prosperi M., Rosen-Zvi M., Schulter E., Sing T., Sonnerborg A., Thompson R., Zazzi M. Conference Proceedings IST Africa 2007 – Maputo (Mozambique), May 9-11, 2007.

​

Analysis of Positional Interdependencies of Mutations in Reverse Transcriptase (Poster) Bazsó F., Borgulya G., Zalányi L., Nepusz T. 1st International Symposium on Genetic and Immune Correlates of HIV infection and vaccine-induced immunity, Hungary, 2007

​

EuResist presentation (Poster) Bazso F. NetSci International Workshop and Conference on Network Science, New York (USA), 2007

​

EuResist presentation (Talk) Bazso F. Saint Laszlo Hospital, Budapest (Hungary), 2007

​

EuResist presentation (Abstract and poster) Bazso F. Proceedings of the IEEE 3rd International Symposium on Computational Intelligence and Intelligent Informatics, Agadir (Morocco), 2007

​

Statistical Comparison of Machine Learning Techniques for Treatment Optimisation of Drug-Resistant HIV-1 Prosperi M., G. Ulivi G., Zazzi M. In: IEEE Computer-Based Medical Systems (June 20-22, 2007)

​

EuResist presentation (Talk) Lengauer T. 3rd Deutsch-Österreichische AIDS Kongress, 2007

​

EuResist presentation (Poster) Lengauer T. 16th International HIV Drug resistance workshop, Barbados, 2007

​

EuResist presentation (Talk) Lengauer T. Bioperspectives, Cologne (Germany), 2007

​

EuResist presentation (Talk) Lengauer T. AREVIR RKI Annual Meeting hosted by Caesar (Center of advanced European science and research), Bonn (Germany), 2007

​

Validation of geno2pheno and THEO on a large independent clinical dataset (Talk and Poster) Lengauer T. 5th European HIV Drug Resistance Workshop, Cascais (Portugal), 2007

​

Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance (Talk) Altmann A., Beerenwinkel N., Sing T., Savenkov I., D¨aumer M., Kaiser R., Rhee S., Fessel J., Shafer R. Statistik (German statistical conference) 2007

EuResist presentation (Talk) Lengauer T. MPG Workshop on System Biology, Berlin (Germany), 2007

​

EuResist presentation (Talk) Lengauer T. CMBI, Nijmegen (Netherlands), 2007

​

EuResist: European data – European interpretation systems (Talk) Rosen-Zvi M., Aharoni E., Altmann A., Kaiser R., Lengauer T., Neuvirth H., Prosperi M., Bazsó F., Incardona F., Zazzi M. AREVIR RKI Annual Meeting hosted by Caesar (Center of advanced European science and research), Bonn (Germany), 2007, Expanded Abstract in the European Journal of Medical Research

​

EuResist: Integrating and exchanging European HIV data (Talk) Peres Y., Bergroth T., Denholm-Price J., Incardona F., Kaiser R., Kent C., Prosperi M., Schuelter E., Sonnerborg A., Zazzi M. AREVIR RKI Annual Meeting hosted by Caesar (Center of advanced European science and research), Bonn (Germany), 2007, Expanded Abstract in the European Journal of Medical Research

​

Geno2pheno-THEO: predicting response to combination ART on a large independent dataset (Abstract) Altmann A., Däumer M., Sing T., Beerenwinkel N., Schülter E., Peres Y., Sonnerborg A., Zazzi M., Kaiser R., Lengauer T. AREVIR-GENAFOR Meeting, Bonn (Germany), April 19-20, 2007, Abstract Presentation.

​

Exploration of multiple modeling techniques for prediction of response to treatment (Abstract) Zazzi M., Aharoni E., Altmann A., Bazsó F., Bidgood P., Borgulya G., Denholm-Price J., Fielder M., Kaiser R., Kent C., Lengauer T., Nepusz T., Neuvirth H., Peres Y., Petroczi A., Prosperi M., Romano L., Rosen-Zvi M., Schuelter E., Sing T., Sonnerborg A., Thompson R., Ulivi G., Zalányi L., Incardona F., EuResist Study Group. 5th European HIV Drug Resistance Workshop, Cascais (Portugal), March 28-30, 2007, Abstract Presentation.

​

The Euresist: clinical genomic analysis of HIV treatments (Talk) Rosen-Zvi M. Dagstuhl seminar on Similarity based Clustering and its Applications in Medicine and Biology, Germany, 2007

​

EuResist presentation (Talk) Kaiser R. AREVIR RKI Annual Meeting hosted by Caesar (Center of advanced European science and research), Bonn (Germany), 2007

​

HIV resistance testing and prediction of new therapies (Talk) Sonnerborg A. Centre Infectious Diseases – West-Tallinn Central Hospital, Tallinn (Hestonia), 2007

​

EuResist presentation (Talk) Zazzi M. Swedish HIV cohort meeting, Sweden, 2007

​

EuResist presentation (Talk) Zazzi M. Annual Italian ARCA meeting, Italy, 2007

​

Detection of HIV minority variants, HIV-gag-mutations and resistance to antiretroviral drugs (Talks) Rolf K. 5th European HIV Drug Resistance Workshop. Cascais (Portugal), 2007

​

EuResist: exploration of multiple modelling techniques for prediction of response to treatment (Talk and poster) Zazzi M. 5th European HIV Drug Resistance Workshop. Cascais (Portugal), 2007

​

EuResist presentation (Talk) Incardona F. International Symposium on Biomedical Informatics in Europe, Barcelona Biomedical Research Park (PRBB), Barcelona (Spain), 2007

​

Modellazione delle dinamiche di resistenza selettiva dell’HIV ed ottimizzazione terapeutica (Talk) Incardona F. CNR-IASI, Rome (Italy), 2007

​

Consistent dimensionality reduction scheme and its application to clinical HIV data (Abstract) Rosen-Zvi M., Neuvirth H., Aharoni E., Zazzi M., Tishby N. NIPS 2006 workshop: Novel Applications of Dimensionality Reduction, Whistler (Canada), December 9, 2006, Abstract Presentation

​

Consistent dimensionality reduction scheme and its application to clinical HIV data (Talk) Rosen-Zvi M. Learning Club at the Hebrew University Jerusalem, Israel, 2006

​

The AREVIR-Project and EuResist; The contribution of mutations in the gag-region of HIV with respect to resistance (Talk) Kaiser R. University of Utrecht, Utrecht (Holand), 2006

​

EuResist presentation (Poster) Rosen-Zvi M. “Novel Applications of Dimensionality Reduction” workshop, The NIPS conference, Vancouver (Canada), 2006

​

Improved prediction of HIV resistance in-vitro by biochemical-driven models (Talk) Rosen-Zvi M. “New Problems and Methods in Computational Biology” workshop, The NIPS conference, Vancouver (Canada), 2006

​

CGL7 – The Seventh Layer of Clinical Genomics (Talk and Poster) Rosen-Zvi M. IBM Watson Institute Workshop on Personalized Medicine: The Role of Multimodal Medical Informatics, December 2006, Hawthorne (USA), 2006

​

MD-Towards the Development of Prognosis Prediction in HIV Patients: Statistical Analysis of a Merged European HIV Database (Poster) Petroczi A. St. George’s Research Day, St. George’s Hospital, Tooting, London (UK), 2006

​

EuResist presentation (Invited lecture) Sonnerborg A. Swedish Medical Association Annual meeting, Sweden, 2006

​

HIV-GRADE and geno2pheno interpretation system (Talk) Kaiser R. geno2pheno, RKI, Berlin (Germany), 2006

​

EuResist presentation (Talk) Sonnerborg A. EMEA assessors meeting, Uppsala (Sweden), 2006

​

Improved prediction of response to antiretroviral combination therapy using evolutionary models (Talk) Altmann A. IST 2006, November 22, Helsinki (Finland), 2006

​

Learning from HIV clinical-genomic data with a Generative-Discriminative approach (Talk) Rosen-Zvi M. (joint work with Aharoni E., Neuvirth-Telem H., Zazzi M., Tishby T.) IST 2006, November 22, Helsinki (Finland), 2006

​

Jensen-Shannon semi-supervised learning and its application to clinical HIV data (Talk) Rosen-Zvi M. Biomedical informatics for optimized treatment of infectious diseases, Helsinki (Finland), 2006

​

Challenges for optimization of treatment of infectious diseases (Talk) Zazzi M. Biomedical informatics for optimized treatment of infectious diseases, Helsinki (Finland), 2006

​

EuResist: Integration of viral genomics with clinical data to predict response to anti-HIV treatment (Talk) Rosen-Zvi M. Seminar “Oltre i Confini dell’Ospedale”, Bologna (Italy), 2006

​

EuResist presentation (Talk) Lengauer T. RWTH Aachen University, Aachen (Germany), 2006

​

EuResist presentation (Invited lecture) Sonnerborg A. Annual Clinical Sciences Lectures, Karolinska University Hospital, Stockholm (Sweden), 2006

​

EuResist presentation (Talk) Lengauer T. Bioinformatics Munich Workshop: From Genomes to Systems Biology, Munich (Germany), 2006

​

EuResist presentation (Talk) Lengauer T. Workshop on Innovative Technologies in the Preventive Health Sector, Enschede (Netherlands), 2006

​

EuResist presentation (Talk) Lengauer T. Workshop on Bioinformatics and Modeling in Biomedicine, Luxembourg, 2006 Use of resistance data in regulatory issues (Talk) Sonnerborg A. European Medicines Evaluation Agency (EMEA), London (UK), 2006 Studies of resistance guided therapy (Talk) Sonnerborg A.

​

EuResist presentation at the Swedish West Regional HIV meeting, Sweden, 2006 EuResist presentation (Talk) Lengauer T. Workshop Wissenschaft für jedermann, Deutsches Museum, Munich (Germany), 2006 Resistenz und Resensitivierung bei PIs (Talk) Kaiser R. Resistenzworkshop, Frankfurt a.M. (Germany), 2006

​

EuResist presentation (Talk) Altmann A. Workshop “Clinical relevance of HIV evolutionary pathways and the genetic barrier to drug resistance”, German society for medical computer science, biometrics and epidemiology, Leipzig (Germany), 2006

​

Salvage therapies from virologists point of view (Talk) Kaiser R. Der Haarte Alltag, Frankfurt a.M. (Germany), 2006

​

Bioinformatic analysis in HIV resistance (Talk) Sonnerborg A. EuResist presentation at the Division of Infectious Diseases, Karolinska University Hospital, Stockholm (Sweden), 2006

​

EuResist presentation (Talk) Lengauer T. Informatik überzeugt, Paderborn (Germany), 2006

​

EuResist presentation (Talk) Bazso F. HIV specialists of the Semmelweiss University, Budapest (Hungary), 2006

​

AIDS Forschung in Saarbrücken – Wie Bioinformatiker den Patienten helfen können (Talk) Nacht der Informatik, Saarbrücken (Germany), 2006

​

EuResist presentation (Talk and Poster) Incardona F. ICT for Bio conference, Brussels (Belgium), 2006

​

Resistance to new drugs (Talk) Kaiser R. Summary of the International Ressitance Meeting at the Post Sitges Meeting, Frankfurt a.M. (Germany), 2006

​

Statistical analysis of a merged European HIV database: towards the development of prognosis prediction in HIV patients (Talk) Petroczi A. EuResist presentation at the Kingston University Postgraduate Research Day, Kingston (UK), 2006

​

p7/p1 and p1/p6-gag cleavage site are associated with specific PR mutations and PI resistance profiles (Poster) Kaiser R. International HIV Resistance Meeting, Sitges (Spain), 2006

​

The EuResist Initiative: Integration of Viral Genomics with Clinical Data to Predict Response of HIV Patients to Treatment (Talk) Rosen-Zvi M. Machine Learning Seminar, IBM Haifa Lab Israel, Haifa (Israel), 2006

​

Biomedical Information Integration for Clinical Genomics (Talk) Rosen-Zvi M. Information Technology for Public Health Seminar, IBM Haifa Lab Israel, Haifa (Israel), 2006

​

HIV-Resistance testing in clinical practice (Talk) Kaiser R. Molekular Diagnostics Meeting, Graz (Germany), 2006

​

EuResist presentation (Talk and Poster) Lengauer T. CUBIC-CDFD, Cologne (Germany), 2006

​

Detection of Minor variants of HIV-Strains (Talk and Poster) Zazzi M., Kaiser R. 4th European Workshop on HIV Drug Resistance, Munich (Germany), 2006

​

Analyse von HIV-Minoritäten-Varianten (Talk) Kaiser R. Jahrestagung der Gesellschaft für Virologie, Munich (Germany), 2006

​

Resistenztestung in clinical setting (Talk) Kaiser R. EuResist presentation at the Chariteé Berlin, Insitut für Virologie, Berlin (Germany), 2006

​

EuResist presentation (Talk) Lengauer T. Workshop on Systems Biology, Berlin (Germany), 2006

​

Evolution of HIV-strains in different patients originating from a single source (Talk) Kaiser R. HIV Abseits der Standards, Zoologic Garden, Cologne (Germany), 2006